<DOC>
	<DOCNO>NCT00681369</DOCNO>
	<brief_summary>purpose study describe way Faslodex use France , patient suffer initial breast cancer , evaluate Faslodex treatment duration determine patient profile</brief_summary>
	<brief_title>Observational Usage Study Faslodex Patients Suffering From Initial Breast Cancer France</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Fulvestrant</mesh_term>
	<criteria>Patients suffer initial breast cancer , treat Faslodex , treatment stop 2007</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>fulvestrant</keyword>
	<keyword>longitudinal study</keyword>
	<keyword>France</keyword>
</DOC>